Delivery Order SPE2DB22D2108-SPE2DB25FU5AK
Award Date 7/8/25
Potential Completion Date 7/9/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract, valued at $6,676.87, is for the supply of 180 tablets of 800 mg Delayed-Release Mesalamine, a medication used to treat inflammatory bowel diseases. The contract has an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,911.42 and an ultimate completion date of June 26, 2025. The contract is for the delivery of 120 tablets of the medication Mesalamine DR 1.2 GM. This is an open competition contract, as it does not have a set-aside designation. Amerisourcebergen Drug Corp is the...
- This is a $3,654.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,231,508 units of the medication Mesalamine DR 1.2 GM Tablet 120S. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,942,947 tablets of Mesalamine DR 1.2 GM, a medication used to treat certain gastrointestinal conditions. The contract has a ceiling value of $2,002.92 and a completion date of April 17, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,563,713,896 tablets of the medication Mesalamine DR 1.2 gram, with a ceiling value of $5,692.07. The contract is a firm fixed price delivery order with a period of performance extending to February 21, 2024. This award is part of a larger Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 180 800-milligram delayed-release mesalamine tablets. The $6,145.71 contract has an ultimate completion date of June 11, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This is a $6,165.32 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product, with a period of performance through June 17, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mesalamine delayed-release tablets, a medication used to treat ulcerative colitis. The contract has a ceiling value of $2,076.04 and a performance period ending on July 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablet units of the medication Mesalamine DR 1.2 GM. The contract has a ceiling value of $4,553.87 and is a firm fixed-price delivery order. The period of performance extends to July 10, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine DR 1.2 GM Tablets. The contract has a ceiling value of $1,810.32 and a period of performance through April 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...